Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Neurologic Disorders Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurologic Disorders Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurologic Disorders Therapeutics Overall Market Size
2.1 Global Neurologic Disorders Therapeutics Market Size: 2022 VS 2030
2.2 Global Neurologic Disorders Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurologic Disorders Therapeutics Players in Global Market
3.2 Top Global Neurologic Disorders Therapeutics Companies Ranked by Revenue
3.3 Global Neurologic Disorders Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Neurologic Disorders Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neurologic Disorders Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurologic Disorders Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Neurologic Disorders Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurologic Disorders Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurologic Disorders Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Central Nervous System (CNS)
4.1.3 Peripheral Nervous System (PNS)
4.2 By Type - Global Neurologic Disorders Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Neurologic Disorders Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Neurologic Disorders Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Neurologic Disorders Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurologic Disorders Therapeutics Market Size, 2022 & 2030
5.1.2 Paralysis
5.1.3 Muscle Weakness
5.1.4 Poor Coordination
5.1.5 Loss of Sensation
5.1.6 Seizures
5.1.7 Confusion
5.1.8 Pain and Altered Levels of Consciousness
5.2 By Application - Global Neurologic Disorders Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Neurologic Disorders Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Neurologic Disorders Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Neurologic Disorders Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Neurologic Disorders Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Neurologic Disorders Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Neurologic Disorders Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Neurologic Disorders Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Neurologic Disorders Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Neurologic Disorders Therapeutics Revenue, 2018-2030
6.3.2 US Neurologic Disorders Therapeutics Market Size, 2018-2030
6.3.3 Canada Neurologic Disorders Therapeutics Market Size, 2018-2030
6.3.4 Mexico Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Neurologic Disorders Therapeutics Revenue, 2018-2030
6.4.2 Germany Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.3 France Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.4 U.K. Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.5 Italy Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.6 Russia Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Neurologic Disorders Therapeutics Market Size, 2018-2030
6.4.8 Benelux Neurologic Disorders Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Neurologic Disorders Therapeutics Revenue, 2018-2030
6.5.2 China Neurologic Disorders Therapeutics Market Size, 2018-2030
6.5.3 Japan Neurologic Disorders Therapeutics Market Size, 2018-2030
6.5.4 South Korea Neurologic Disorders Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Neurologic Disorders Therapeutics Market Size, 2018-2030
6.5.6 India Neurologic Disorders Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Neurologic Disorders Therapeutics Revenue, 2018-2030
6.6.2 Brazil Neurologic Disorders Therapeutics Market Size, 2018-2030
6.6.3 Argentina Neurologic Disorders Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurologic Disorders Therapeutics Revenue, 2018-2030
6.7.2 Turkey Neurologic Disorders Therapeutics Market Size, 2018-2030
6.7.3 Israel Neurologic Disorders Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Neurologic Disorders Therapeutics Market Size, 2018-2030
6.7.5 UAE Neurologic Disorders Therapeutics Market Size, 2018-2030
7 Neurologic Disorders Therapeutics Companies Profiles
7.1 Biogen Inc.
7.1.1 Biogen Inc. Company Summary
7.1.2 Biogen Inc. Business Overview
7.1.3 Biogen Inc. Neurologic Disorders Therapeutics Major Product Offerings
7.1.4 Biogen Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Biogen Inc. Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Company Summary
7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Company Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Neurologic Disorders Therapeutics Major Product Offerings
7.4.4 Novartis AG Neurologic Disorders Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Major Product Offerings
7.5.4 Pfizer Inc. Neurologic Disorders Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer